Premium
Treatment of Bladder Carcinoma Using a Germ Cell Chemotherapy Protocol
Author(s) -
WILLIAMS GRANT,
COLBECK R. A.,
CRAWFORD S. M.
Publication year - 1990
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1990.tb14789.x
Subject(s) - transitional cell carcinoma , germ cell , chemotherapy , germ cell tumors , medicine , carcinoma , oncology , cell , urinary bladder , cancer research , pathology , urology , biology , bladder cancer , cancer , biochemistry , genetics , gene
Summary— Elevated levels of circulating β‐human chorionic gonadotrophin (β‐HCG) are commonly associated with a variety of tumours of germ cell origin. Other carcinomas may possess choriocarcinomatous elements but only rarely have there been reports of transitional cell carcinomas of the bladder associated with raised germ cell tumour markers, possibly because assays are not routinely performed. We present 3 patients with advanced transitional cell carcinoma of the bladder, 2 with metastatic and 1 with locally invasive disease, who had raised levels of germ cell tumour markers. These patients were therefore treated with combination chemotherapy appropriate to such tumours, with excellent results, as shown by clinical improvement and return to normal of tumour marker levels. Recent reports of the association between bladder carcinoma and ectopic synthesis of β‐HCG are reviewed. It was concluded that the production of β‐HCG is probably not rare, but that when it is found, the adoption of an appropriate chemotherapeutic regime may be successful.